SLC7A11 and central nervous system cancer: The IDH1- mutated glioma had significantly increased SLC7a11 expression following CMD, while the IDH1-wild-type glioma trended towards an increase of SLC7a11 (p = 0.08) (Fig. 2c, d ii. ).